Abstract:
Objective To analyse the relationship between non-invasive central aortic pressure and left ventricular hypertrophy (LVH) and to explore the predictive value of non-invasive central aortic pressure in the early diagnosis of LVH in children with essential hypertension (EH).
Methods The clinical data of 169 children with EH who were hospitalized in the Department of Pediatric Cardiology, Capital Center for Children's Health, Capital Medical University from April 2021 to August 2022 were retrospectively collected, and the non-invasive central aortic pressure was detected by SphygmoCor CVMS central blood pressure assessment system. LVH was determined based on echocardiographic parameters. Patients were divided into LVH group and non-LVH group (NLVH group). The clinical data of the two groups were compared. Logistic regression analysis was used to explore the influence factors of LVH, and a nomogram model for predicting LVH risk was constructed. Receiver operating characteristic (ROC) curve and calibration curve were used to evaluate the prediction efficiency of the nomogram model, and decision curve analysis (DCA) was conducted to verify the clinical applicability of the model.
Results A total of 169 children with EH were included in this study, including 51 cases in LVH group and 118 cases in NLVH group. The peripheral systolic blood pressure (129.71±10.64) vs (123.59±11.17) mmHg, t=−3.31, P<0.01, peripheral pulse pressure (57.18±10.67) vs (51.77±9.75) mmHg, t=−3.21, P<0.01, central systolic blood pressure (107.47±8.56) vs (103.13±8.67) mmHg, t=−3.00, P<0.01, and central pulse pressure CPP: (32.90±6.75) vs (29.14±5.94) mmHg, t=−3.63, P<0.01 in the LVH group were significantly higher than those in the NLVH group. Multivariate logistic regression analysis showed that elevated non-invasive CPP was the independent risk factor for LVH (OR=1.12, 95%CI 1.04–1.21, P<0.05). The nomogram model was constructed based on age, gender, body mass index, grade of hypertension, central systolic blood pressure, CPP, fasting insulin, fatty liver disease, and hyperuricemia. ROC curve analysis showed that the area under the curve (AUC) was 0.80 (95%CI 0.72–0.87), with a sensitivity of 73.5% and a specificity of 76.7%. The calibration curve showed a good model calibration, and the DCA demonstrated a favorable clinical utility.
Conclusion Elevated non-invasive CPP is an independent risk factor for LVH, and non-invasive CPP has a good diagnostic predictive value for LVH in children with EH.